US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 6.220
  • +0.410+7.06%
Close Nov 6 16:00 ET
  • 6.260
  • +0.040+0.64%
Post 18:35 ET
423.47MMarket Cap-2528P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amylyx Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
0
-100.00%
EPS
-0.56
-288.30%
Analyst Rating
Buy

Nov 6, 2024

Amylyx Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 0.000 --
Nov 7, 2024 2024/Q3 -- / 0.000 --
Aug 8, 2024 2024/Q2 -1.023M / 8.530M --
May 9, 2024 2024/Q1 88.643M / 98.346M --
Feb 22, 2024 2023/Q4 108.449M / 107.043M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q3-- / 0.000--
Aug 8, 20242024/Q2-1.023M / 8.530M--
May 9, 20242024/Q188.643M / 98.346M--
Feb 22, 20242023/Q4108.449M / 107.043M--

Unlock Free Earnings Estimates

Amylyx Pharmaceuticals Earnings Reports

  • Amylyx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 19:19

  • Amylyx Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 19:17

  • Amylyx Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 22 21:26

  • Amylyx Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 20:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Buy

    • Buy

      40.00%

    • Hold

      60.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data